Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization
- 1 March 1999
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 47 (2) , 119-123
- https://doi.org/10.1016/s0939-6411(98)00064-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Delivery of antisense oligonucleotides by means of pH-sensitive liposomesJournal of Controlled Release, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?Journal of Controlled Release, 1996
- Intracellular Distribution and Mechanism of Delivery of Oligonucleotides Mediated by Cationic LipidsPharmaceutical Research, 1996
- Does antisense exist?Nature Medicine, 1995
- Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patientsThe Lancet, 1995
- Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.Proceedings of the National Academy of Sciences, 1994
- Patterns of intracellular compartmentalization, trafficking and acidification of 5×-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cellsNucleic Acids Research, 1994
- Adsorption of Oligonucleotides onto Polyisohexylcyanoacrylate Nanoparticles Protects Them Against Nucleases and Increases Their Cellular UptakePharmaceutical Research, 1994
- Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cellsBiochemistry, 1993